Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second ...

Haystack, a leading modern intranet provider, today announced its collaboration with Google Cloud to integrate Google Cloud’s ...

(NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, today announced the launch of Vertex for Salesforce Revenue Cloud. This integration brings together Vertex’s ...

Vertex, Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a global provider of tax technology solutions, has been announced at Oracle CloudWorld the winner in the 2024 Oracle Partner Awards – Best in ...

Discover why Vertex stock is undervalued with the potential of VX-548 as a groundbreaking pain treatment drug in the ...

No patients have received Casgevy, CRISPR Therapeutics and Vertex Pharmeceuticals’ recently approved sickle cell gene therapy ...

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are ...

He is also the co-author of Control Your Cash: Making Money Make Sense. Getty Images / jetcityimage Companies of a certain size often can't wait to "go public" and sell their shares on a stock ...

BigEndian Semiconductors, a fabless-semiconductor design startup, raised $3 million in a funding round led by Vertex Ventures SEA & India. The funds will be used to expand the company’s engineering ...